PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 43 filers reported holding PSYCHEMEDICS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $399,000 | -79.8% | 43,754 | -77.6% | 0.01% | -78.2% |
| Q2 2019 | $1,972,000 | -48.8% | 195,421 | -28.8% | 0.06% | -47.6% |
| Q1 2019 | $3,850,000 | -14.0% | 274,416 | -2.8% | 0.10% | -18.6% |
| Q4 2018 | $4,478,000 | -17.4% | 282,186 | -2.1% | 0.13% | +6.6% |
| Q3 2018 | $5,420,000 | +377.5% | 288,147 | +388.7% | 0.12% | +365.4% |
| Q2 2018 | $1,135,000 | +24.0% | 58,967 | +37.7% | 0.03% | +23.8% |
| Q1 2018 | $915,000 | +82.6% | 42,831 | +17.4% | 0.02% | +110.0% |
| Q2 2016 | $501,000 | -53.3% | 36,497 | -53.2% | 0.01% | -54.5% |
| Q1 2016 | $1,073,000 | +38.5% | 78,023 | +2.1% | 0.02% | +57.1% |
| Q4 2015 | $775,000 | -42.2% | 76,445 | -19.3% | 0.01% | -12.5% |
| Q2 2014 | $1,341,000 | -49.2% | 94,729 | -38.5% | 0.02% | -50.0% |
| Q1 2014 | $2,638,000 | -41.3% | 154,001 | -49.7% | 0.03% | -43.9% |
| Q4 2013 | $4,495,000 | -26.0% | 306,009 | -33.2% | 0.06% | -31.3% |
| Q3 2013 | $6,071,000 | -2.6% | 458,215 | -21.0% | 0.08% | -2.4% |
| Q2 2013 | $6,233,000 | – | 580,372 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 301,282 | $4,227,000 | 3.76% |
| QUANTUM CAPITAL MANAGEMENT | 56,179 | $788,000 | 0.42% |
| Mill Road Capital Management LLC | 14,896 | $209,000 | 0.27% |
| Gs Investments, Inc. | 15,300 | $214,659,000 | 0.17% |
| North Star Investment Management Corp. | 84,948 | $1,192,000 | 0.14% |
| CRAWFORD INVESTMENT COUNSEL INC | 310,870 | $4,362,000 | 0.13% |
| RBF Capital, LLC | 78,495 | $1,101,000 | 0.13% |
| Uniplan Investment Counsel, Inc. | 123,339 | $1,730,000 | 0.11% |
| DEPRINCE RACE & ZOLLO INC | 274,416 | $3,850,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 446,074 | $6,258,000 | 0.07% |